Article
VIDEO: Novel microcapsules show promise in hemophilia A with inhibitory antibodies
SAN DIEGO – Novel microcapsules loaded with factor VIII outperformed systemic factor VIII infusions in models of hemophilia A with inhibitory...
Article
VIDEO: Y90 radioembolization beat chemoembolization in liver cancer
Liver cancer took nearly four times longer to progress after yttrium-90 radioembolization than after conventional transarterial chemoembolization...
Article
Yoga holds up to medications, walking for irritable bowel syndrome
Yoga may be a feasible and safe add-on therapy for patients with irritable bowel syndrome, based on a systematic review of six randomized...
News
Mobile health indexes accurately detected active inflammatory bowel disease
Mobile health indexes for remotely monitoring Crohn’s disease and ulcerative colitis accurately identified clinically active disease, and changed...
Article
Second course of rifaximin edges out placebo in IBS-D trial
Patients with diarrhea-predominant irritable bowel syndrome who responded to rifaximin but relapsed after completing treatment were significantly...
Article
The Liver Meeting 2016 debrief – key abstracts
BOSTON - Amid a plethora of quality research, several abstracts stood out at the annual meeting of the American Association for the Study of Liver...
Article
HCV patients with early-stage hepatocellular carcinoma can achieve SVR
Among patients with hepatocellular carcinoma, rates of sustained viral response to direct-acting regimens for hepatitis C virus were 79% for...
Article
Metabolomics of liquid biopsies offer a comprehensive look at NAFLD
BOSTON - Metabolomics of liquid biopsies noninvasively identified nonalcoholic fatty liver disease with and without steatosis, and assessed the...
Article
Sofosbuvir/velpatasvir improved patient-reported outcomes, knocked out HCV genotypes 1-6
BOSTON – When given with ribavirin, a fixed-dose combination of sofosbuvir/velpatasvir (Epclusa) achieved a sustained viral response at 12 weeks (...
Article
NAFLD can regress with weight loss, activity
BOSTON – All phenotypes of nonalcoholic fatty liver disease can progress or regress even without pharmacologic intervention, according to a...
Article
Tumor boards linked to improved survival in hepatocellular carcinoma
BOSTON – Veterans were about 13% less likely to die within 5 years of hepatocellular carcinoma diagnosis when multidisciplinary tumor boards...
Article
Study eyed zinc for slowing progression of chronic liver disease
BOSTON - Oral zinc supplementation was associated with maintenance of liver function and suppression of hepatocellular carcinoma in a...
Article
MBX-8025 yields ‘striking’ efficacy results but new safety signal in primary biliary cholangitis
BOSTON - The investigational peroxisome proliferator-activated receptor delta agonist MBX-8025 exhibited a "striking anticholestatic effect"...